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Figure 1: Number of pig herds with reported use of specific active antimicrobial ingredients by route of administration; CIPARS 
Farm-Swine Surveillance 2013 (n = 89).
Figure 2: Reported antimicrobial use for treatment or control of specific diseases in CIPARS grower-finisher herds, by disease 
status; CIPARS Farm Swine Surveillance 2013 
Positive= “confirmed positive” or “likely positive”
Negative = “confirmed negative” or “likely negative”.
Positive & Antibiotics = Positive for a disease and used an antibiotic to control that disease 
Positive & No Antibiotics = Positive for a disease and did not use antibiotics to control that disease 
Negative & Antibiotics = Negative for a disease and used antibiotics to control that disease 
Negative & No Antibiotics = Negative for a disease and did not use antibiotics to control that disease
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Few countries have introduced monitoring of antimicrobial usage (AMU) per animal species. Such 
an achievement is an objective of the ESVAC project (European Surveillance of Veterinary Antimicrobial 
Consumption). Implementing these monitoring systems would allow detailed AMU comparisons between 
countries enabling an evaluation of interventions to reduce antimicrobial consumption effectively.
In line with the abovementioned, a Monte-Carlo simulation model (MCSM) was developed to estimate 
AMU per species in Switzerland in the period 2006-2012. PERT distributions were generated by combining 
sales data, information collected from the Swiss Veterinary Drug Compendium and data derived from a 
field study on Swiss prescription patterns. Obtained outputs allowed extrapolating from sales data to the 
proportion of AMU by each species, at antimicrobial class level.
AMU in Danish pigs was calculated as mg/Population Correction Unit (PCU) using the Danish Integrated 
Antimicrobial Resistance Monitoring and Research Programme (DANMAP) and ESVAC as data sources. Pig 
AMU was compared between the two countries.
In general, MCSM results indicated a decreasing trend in Swiss AMU for all species. Pigs dominated AMU 
in Switzerland (varying between 111 mg/PCU in 2008 and 78 mg/PCU in 2012), over cattle (from 89 mg/
PCU in 2008 to 73 mg/PCU in 2012) and poultry (from 21 mg/PCU in 2006 to 9 mg/PCU in 2012). Danish pig 
AMU was lower than Swiss pig AMU with values ranging between 44 and 57 mg/PCU. Additionally, the use 
of different antimicrobial classes in pigs varied between the countries.
Comparisons should be assessed with caution as different data collection strategies and methodologies 
were used to quantify AMU. Moreover, antimicrobial potency was not considered in these AMU estimates. 
Nevertheless, results suggest that there is still room for an AMU reduction in the Swiss pig sector. Further 
efforts should be made to understand what drives AMU and consumption patterns in Switzerland and other 
countries.
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